Review Article
Polymeric Nanogels as Versatile Nanoplatforms for Biomedical Applications
Table 3
NGs for the management of pain.
| NG composition | Type of NG | Drug/agent used | Method of preparation | Results and applications | References |
| NIPAAM, MAA | Magnetic NG | Bupivacaine | Free radical emulsion polymerization method | Rapid release at low temperature and pH Effective for the treatment of ankle block | [133] | Pluronic F127, hyaluronic acid (HA) | Thermogel | Bupivacaine | | Easy to inject in situ gel for localized affect sustained release profile Less cytotoxic | [109] | Chitosan | Thermogel | Rupivacaine | | Controlled release Efficacious delivery system for local anesthetic affect | [134] | Poly(N-isopropylacrylamide) (PNIPAM) | Temperature-sensitive NG | Bupivacaine | Polymerization | Less cytotoxic enhanced drug uptake | [135] | Alginate, chitosan | NG | Bupivacaine | | Acceptable cytotoxicity and stability Slower drug release | [136] | Poly (e-caprolactone)–poly(ethylene glycol)–poly(e-caprolactone) (PCL–PEG–PCL) Pluronic F-127 | Thermoresponsive NG | Lidocaine | Emulsion solvent evaporation method | Prolonged anesthetic affect with lesser toxicity Enhanced retention of local anesthetic | [137] | Methacrylic acid–ethyl acrylate cross-linked with diallyl phthalate | pH-sensitive NG | Bupivacaine | Emulsion polymerization | Enhanced pH-dependent anesthetic affect | [138] |
|
|